Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2/3 2Phase NA 1Phase 1 1

Status

Unknown 1Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 1

Conditions

Fatigue 7Neoplasms 4Brain Neoplasms 3Depression 2Asthenia 2Recurrence 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Neoplasm Metastasis 1Meningioma 1Gliosarcoma 1Glioma, Subependymal 1Glioma 1Glioblastoma 1Gastrointestinal Neoplasms 1Ependymoma 1Central Nervous System Neoplasms 1Breast Neoplasms 1Astrocytoma 1

Interventions

Paclitaxel 20Gemcitabine 16Dexamethasone 16Bevacizumab 16Docetaxel 15Oxaliplatin 14Cyclophosphamide 13Carboplatin 12Capecitabine 12Sorafenib 11Fluorouracil 11Leucovorin 10Cisplatin 10pembrolizumab 9Pemetrexed 9Epoetin Alfa 9venetoclax 8Prednisone 8Fentanyl 8Drug Therapy 8Doxorubicin 8atezolizumab 7Rivaroxaban 7Rituximab 7Darbepoetin alfa 7Anastrozole 7Panitumumab 6Ondansetron 6Morphine 6Irinotecan 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Neoplasms × Methylphenidate × Clear all
NCT06905587 2026-04-23

EMBRAIN

Odense University Hospital

Phase 3 Recruiting
50 enrolled
CNS

Brain Neoplasms, Neoplasms

NCT05041946 2022-09-29

Patient Controlled Methylphenidate for Cancer Related Fatigue: A Double Blind, Randomized, Placebo Controlled Trial

M.D. Anderson Cancer Center

Phase 3 Completed
112 enrolled

Fatigue, Neoplasms

NCT01497548 2011-12-22

Study of Methylphenidate as Add on Therapy in Depressed Cancer Patients

University of Malaya

Phase 3 Unknown
120 enrolled

Depression, Neoplasms

NCT00273741 2009-12-07

Ritaline

University Hospital, Grenoble

Phase 3 Terminated
39 enrolled

Asthenia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡